Shares of Arecor Therapeutics plc (LON:AREC – Get Free Report) dropped 1.3% during trading on Tuesday . The stock traded as low as GBX 74 ($0.91) and last traded at GBX 74 ($0.91). Approximately 204 shares were traded during trading, a decline of 90% from the average daily volume of 2,132 shares. The stock had previously closed at GBX 75 ($0.93).
Arecor Therapeutics Stock Performance
The company has a market cap of £27.66 million, a PE ratio of -261.61 and a beta of -0.18. The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51. The business’s 50 day moving average is GBX 73.66 and its two-hundred day moving average is GBX 82.01.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a biopharmaceutical company transforming patient care by bringing innovative medicines to market. Through the enhancement of existing medicines using our Arestat™ technology, we are developing a broad portfolio of therapies as part of our proprietary pipeline and through partnerships with leading pharmaceutical and biotech companies.
Read More
- Five stocks we like better than Arecor Therapeutics
- How Technical Indicators Can Help You Find Oversold Stocks
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is the NASDAQ Stock Exchange?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Where Do I Find 52-Week Highs and Lows?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
